Therapy Areas: Diabetes
Renalytix reports real-world impact of KidneyIntelX on targeted kidney disease treatment
16 April 2025 - Precision medicine company Renalytix plc (LSE: RENX, OTCQB: RNLXY) on Wednesday announced new clinical data demonstrating the positive impact of its KidneyIntelX test on prescribing pa...
Aditxt reports positive preclinical results from Mayo Clinic study supporting ADI-100 for autoimmune diseases
14 April 2025 - Aditxt Inc (NASDAQ: ADTX) reported on Monday that its wholly owned subsidiary Adimune Inc announced positive results from preclinical studies conducted by the Mayo Clinic, supporting t...
Poxel secures new patent in Japan for Imeglimin use in type 2 diabetic patients with renal impairment
31 March 2025 - Clinical stage biopharmaceutical company Poxel SA (Euronext Paris:POXEL) announced on Monday that the Japanese Patent Office has granted a new patent (number 7635474) covering the use ...
Langhua Pharmaceutical passes US FDA's on-site inspection
31 March 2025 - Viva Biotech Holdings announced on Friday that its wholly-owned subsidiary, Zhejiang Langhua Pharmaceutical Co., Ltd., successfully completed a cGMP on-site inspection by the US Food a...
Arecor signs collaboration deal with global pharma partner
26 March 2025 - Biopharmaceutical company Arecor Therapeutics plc (AIM: AREC) announced on Wednesday that it has entered into a formulation study agreement with a major global pharmaceutical company t...
ANI Pharmaceuticals secures FDA approval for ILUVIEN label expansion
14 March 2025 - Biopharmaceutical company ANI Pharmaceuticals Inc (Nasdaq:ANIP) announced on Friday that the US Food and Drug Administration has approved an expanded label for ILUVIEN, adding an indic...